[Federal Register Volume 75, Number 202 (Wednesday, October 20, 2010)]
[Notices]
[Pages 64743-64744]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-26454]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this 
is notice that on September 3, 2010, Johnson Matthey, Inc., 
Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey 
08066-1742, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as an importer of the basic 
classes of controlled substances listed in schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Phenylacetone (8501).......................   II
Coca Leaves (9040).........................   II
Thebaine (9333)............................   II
Opium, raw (9600)..........................   II
Noroxymorphone (9668)......................   II
Poppy Straw Concentrate (9670).............   II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances as raw 
materials for use in the manufacture of bulk controlled substances for 
distribution to its customers.
    No comments, objections, or requests for any hearings will be 
accepted on any application for registration or re-registration to 
import crude opium, poppy straw, concentrate of poppy straw, and coca 
leaves. As explained in

[[Page 64744]]

the Correction to Notice of Application pertaining to Rhodes 
Technologies, 72 FR 3417 (2007), comments and requests for hearings on 
applications to import narcotic raw material are not appropriate.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic classes of controlled 
substances listed in schedule I or II, which fall under the authority 
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in 
the circumstances set forth in 21 U.S.C. 958(i), file comments or 
objections to the issuance of the proposed registration and may, at the 
same time, file a written request for a hearing on such application 
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 
1316.47.
    Any such comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than November 19, 2010.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR 1301.34(b), (c), 
(d), (e), and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, (40 FR 43745), all applicants 
for registration to import a basic classes of any controlled substances 
in schedule I or II are, and will continue to be, required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 
21 CFR Sec.  1301.34(b), (c), (d), (e), and (f) are satisfied.

    Dated: October 8, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-26454 Filed 10-19-10; 8:45 am]
BILLING CODE 4410-09-P